Netflix Stock Price Soars After Earnings Report Record New Memberships
Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the
If you invested $1000 in Chipotle Mexican Grill (NYSE:CMG) 5 years ago, here's how much it's worth today
They say, “If it looks like a restaurant, cooks food like a restaurant, and serves food like a restaurant, then it’s probably a restaurant.”. However, this might not be how investors see Chipotle Mexican Grill ( NYSE:CMG ). Chipotle’s stock is currently trading at a P/E ratio of around 54, while many
ReGen III Announces Settlement of Debenture Interest with Shares, Sale of Non-Core Asset, and Patents Update
Newsfile
3 hours ago
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) (FSE: PN4) ("ReGen III" or the "Company"), a leading clean technology company specializing in the upcycling of used motor oil ("UMO") into high
Clara Technologies Corp. Announces Changes to The Board of Directors
Newsfile
4 hours ago
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2025) - Clara Technologies Corp. (CSE: CLTE) (the "Company") announces today that effective May 31st, 2025, George Kovalyov has resigned as Director of the Company and Peter Field has been appoin
Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML
GlobeNewswire Inc.
8 hours ago
– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of
Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025
GlobeNewswire Inc.
Yesterday at 5:12 PM GMT
Median DOR of 21.7 months with 80% of responders achieving a deep response (≥80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast to
Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated Advanced Renal Cell Carcinoma at ASCO
GlobeNewswire Inc.
Yesterday at 2:45 PM GMT
Data Highlights Transformative Promise of CAR T in Solid TumorsPhase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved
Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire Inc.
Yesterday at 2:00 PM GMT
- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and we
OPPO and the UEFA Champions League Final: Powering Football Innovation On and Off the Pitch
Newsfile
Yesterday at 1:45 PM GMT
Munich, Germany--(Newsfile Corp. - June 1, 2025) - The 2024/25 UEFA Champions League season reached its spectacular conclusion on 31 May at Munich Football Arena. As the Official Smartphone Product Partner of the prestigious competition fo
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce costs, making la
Robert Stewart Jr., Virginia Entrepreneur, Launches Scholarship and Grant Programs to Support College Students Nationwide
Newsfile
Yesterday at 2:06 AM GMT
A respected Virginia-based entrepreneur and community leader, has launched two $1,000 scholarship and grant opportunities for college-bound students: one for aspiring criminal justice majors and another for first- or second-year students with entrepr
PetroFrontier Corp. Provides Update on the Delay in Filing of its 2024 Annual Financial Statements and Announces Delay in Filing of its Q1 Interim Financial Statements
Newsfile
May 31, 2025 9:41 PM GMT
Calgary, Alberta--(Newsfile Corp. - May 31, 2025) - PetroFrontier Corp. (TSXV: PFC) ("PetroFrontier" or the "Company") announces that, further to its news releases issued on May 2 and 16, 2025 whereby the Company announced that the Alberta Securities
